Free online seminar Thursday 15th April 2021, 1-2pm AEDT.
This seminar will be co-presented by Prof. Karlheinz Peter and Dr. Yung-Chih Chen
Prof. Karlheinz Peter
Targeting intraplaque haemorrhage in mice and humans to detect and treat plaque instability
Professor Karlheinz Peter is Head of the Baker Department of Cardiometabolic Health at Melbourne University and Deputy Director and Head of the Atherothrombosis and Vascular Biology laboratory at the Baker Heart and Diabetes Institute. He is an interventional cardiologist at the Alfred Hospital and Professor of Medicine and Immunology at Monash University. He is a NHMRC L 3 Investigator. Prof Peter’s research is strongly orientated towards clinical translation. His achievements include establishing diagnostic tests for detection of thrombi and vulnerable plaques, and developing novel, long sought after approaches for anti thrombotic and anti inflammatory therapy with low risk of bleeding side effects.
Dr. Yung Chih Chen
Trimethylamine N oxide a biomarker, bystander, or the magical therapeutic target for atherosclerotic plaque stabilisation?
Chen (aka Ben) is a qualified veterinary doctor who specialized in small animal surgery. He obtained his Ph D about 10 years ago. He developed a unique Tandem stenosis mouse model and since then have trained other (national and international) researchers to adopt the model for their research in plaque instability. He was awarded the Postdoctoral Fellowship and the prestigious Paul Korner Innovation Award for the highest ranked fellowship application by the National Heart Foundation of Australia (2015-16) and Future Leader Fellowship Level 1 (2019-2022) and prestigious Baker Fellowship (2019-2023). He is a group leader in the atherothrombosis lab and his current research is focusing on gut microbiota modulation for plaque stabilisation.
April 08 2021